[(3-aryl-1,2-benzisoxazol-6-yl)oxy]acetic acids. A new diuretic series. 1982

G M Shutske, and L L Setescak, and R C Allen, and L Davis, and R C Effland, and K Ranbom, and J M Kitzen, and J C Wilker, and W J Novick

A series of [(3-aryl-1,2-benzisoxazol-6-yl)oxy]acetic acids was synthesized and tested for diuretic activity in saline-loaded mice and in conscious, water-loaded dogs. The structural requirements for good diuretic activity in both mice and dogs were found to be very specific. In summary, the compounds with the best diuretic activity (13i, 13q, and 13ff) were substituted with a 2-fluorophenyl group at the 3 position and chlorine or bromine at the 7 position. Compound 13ff, [(7-bromo-3-(2-fluorophenyl)-1,2-benzisoxazol-6-yl]oxy]acetic acid (HP 522), was found to be moderately uricosuric in chimpanzees and was selected for further development.

UI MeSH Term Description Entries
D007555 Isoxazoles Azoles with an OXYGEN and a NITROGEN next to each other at the 1,2 positions, in contrast to OXAZOLES that have nitrogens at the 1,3 positions. Isoxazole
D008297 Male Males
D010080 Oxazoles Five-membered heterocyclic ring structures containing an oxygen in the 1-position and a nitrogen in the 3-position, in distinction from ISOXAZOLES where they are at the 1,2 positions. Oxazole,1,3-Oxazolium-5-Oxides,Munchnones,1,3 Oxazolium 5 Oxides
D004232 Diuretics Agents that promote the excretion of urine through their effects on kidney function. Diuretic,Diuretic Effect,Diuretic Effects,Effect, Diuretic,Effects, Diuretic
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014528 Uricosuric Agents Gout suppressants that act directly on the renal tubule to increase the excretion of uric acid, thus reducing its concentrations in plasma. Uricosuric Agent,Agent, Uricosuric,Agents, Uricosuric
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

G M Shutske, and L L Setescak, and R C Allen, and L Davis, and R C Effland, and K Ranbom, and J M Kitzen, and J C Wilker, and W J Novick
June 2009, Acta crystallographica. Section E, Structure reports online,
G M Shutske, and L L Setescak, and R C Allen, and L Davis, and R C Effland, and K Ranbom, and J M Kitzen, and J C Wilker, and W J Novick
November 1988, Acta crystallographica. Section C, Crystal structure communications,
G M Shutske, and L L Setescak, and R C Allen, and L Davis, and R C Effland, and K Ranbom, and J M Kitzen, and J C Wilker, and W J Novick
March 1986, Journal of medicinal chemistry,
G M Shutske, and L L Setescak, and R C Allen, and L Davis, and R C Effland, and K Ranbom, and J M Kitzen, and J C Wilker, and W J Novick
June 1976, Journal of medicinal chemistry,
G M Shutske, and L L Setescak, and R C Allen, and L Davis, and R C Effland, and K Ranbom, and J M Kitzen, and J C Wilker, and W J Novick
December 1982, Japanese journal of pharmacology,
G M Shutske, and L L Setescak, and R C Allen, and L Davis, and R C Effland, and K Ranbom, and J M Kitzen, and J C Wilker, and W J Novick
April 1976, Journal of medicinal chemistry,
G M Shutske, and L L Setescak, and R C Allen, and L Davis, and R C Effland, and K Ranbom, and J M Kitzen, and J C Wilker, and W J Novick
April 1976, Journal of medicinal chemistry,
G M Shutske, and L L Setescak, and R C Allen, and L Davis, and R C Effland, and K Ranbom, and J M Kitzen, and J C Wilker, and W J Novick
May 1987, Chemical & pharmaceutical bulletin,
G M Shutske, and L L Setescak, and R C Allen, and L Davis, and R C Effland, and K Ranbom, and J M Kitzen, and J C Wilker, and W J Novick
April 2013, Acta crystallographica. Section E, Structure reports online,
G M Shutske, and L L Setescak, and R C Allen, and L Davis, and R C Effland, and K Ranbom, and J M Kitzen, and J C Wilker, and W J Novick
October 1982, Journal of medicinal chemistry,
Copied contents to your clipboard!